• Home
  • Sitemap
  • Help
  • Technical Support
  • Contact
Toolbar - View Selection
 
Items 1 of 1
ALX-550-411 Revised 11-Apr-07
LY2183240
Add to Clipboard
SYNONYMS 5-Biphenyl-4-ylmethyltetrazole-1-carboxylic acid dimethylamide
PRODUCT LINE Neurobiology
PRODUCT CATEGORY Anandamide Uptake Inhibitors
Ordering Information
Product Numbers: Format: Size: Unit Price: Quantity: Add To Cart
ALX-550-411-M010   10 mg 60.00 USD Add To Cart
ALX-550-411-M050   50 mg 240.00 USD Add To Cart
Product Specification
FORMULA: C17H17N5O
MW: 307.4
CAS NUMBER: 874902-19-9
PURITY: ≥98% (TLC)
APPEARANCE: White to off-white solid.
SOLUBILITY: Soluble in DMSO or dimethyl formamide.
SHIPPING: SHIPPED ON BLUE ICE
LONG TERM STORAGE: -20°C

Product Description
Initially described as potent, competitive small molecule inhibitor of anandamide uptake. Has recently been shown to inhibit fatty acid amide hydrolase (FAAH) and several additional serine hydrolases.
Product Specific Literature References
Identification of a high-affinity binding site involved in the transport of endocannabinoids: S.A. Moore, et al.; PNAS 102, 17852 (2005) Abstract; Full Text
Toward an anandamide transporter: R. Mechoulam and D.G. Deutsch; PNAS 102, 17541 (2005) Abstract
The putative endocannabinoid transport blocker LY2183240 is a potent inhibitor of FAAH and several other brain serine hydrolases: J.P. Alexander and B.F. Cravatt; JACS 128, 9699 (2006) Abstract
Pharmacological characterization of endocannabinoid transport and fatty acid amide hydrolase inhibitors: A.K. Dickason-Chesterfield, et al.; Cell. Mol. Neurobiol. 26, 407 (2006) Abstract
Further Categories Containing This Product:
Fatty Acid Amide Hydrolase [FAAH] / Related Products
 
 

Your items will be kept only for the duration of your visit.